SCHEMBL6907366

SCHEMBL6907366

CCC(=O)N(CC(N)=O)c1cccc(O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.43
PARP1 P09874 1/20 0.39
HSD17B1 P14061 3/20 0.38
HSD17B2 P37059 3/20 0.38
TP53 P04637 2/20 0.37
NPC1 O15118 1/20 0.37
GPX4 P36969 1/20 0.37
RAB9A P51151 1/20 0.37
PAX8 Q06710 1/20 0.37
PTGDR2 Q9Y5Y4 2/20 0.37
CYP2C8 P10632 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
USP2 O75604 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
OPRM1 P35372 1/20 0.36
SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6907477 0.86 ALDH1A1 (0.49) ALDH1A1CYP3A4TSHRHSD17B1HSD17B2
SCHEMBL6906900 0.82 ALDH1A1 (0.45) ALDH1A1CYP3A4TSHRHSD17B1HSD17B2
SCHEMBL6907879 0.82 ALDH1A1 (0.45) ALDH1A1CYP3A4TSHRUSP2HPGD
SCHEMBL6908846 0.82 TP53 (0.54) ALDH1A1CYP3A4TSHRTP53NPC1
SCHEMBL6901537 0.81 CA2 (0.40) ALDH1A1CYP3A4TSHRTP53PTGDR2
SCHEMBL6906982 0.79 LMNA (0.44) ALDH1A1CYP3A4PTGDR2USP2HPGD
SCHEMBL11433584 0.78 ALDH1A1 (0.58) ALDH1A1CYP3A4TSHRPARP1HSD17B1
SCHEMBL6064822 0.76 ALDH1A1 (0.47) ALDH1A1CYP3A4TSHRPARP1TP53
SCHEMBL6907408 0.74 ALDH1A1 (0.49) ALDH1A1CYP3A4TSHRPARP1HSD17B1
SCHEMBL8756573 0.74 ALDH1A1 (0.53) ALDH1A1CYP3A4TSHRTP53NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6824786-B2 TOPICAL APPLYING COSMETIC YU RUEY J (US) 2004-11-30 US claimed
EP-1455734-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES Yu, Ruey J., Dr. (US) 2004-09-15 EP claimed
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives YU RUEY J (US) 2003-06-12 US claimed
WO-2003045338-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES YU RUEY J (US) 2003-06-05 WO claimed
US-6824786-B2 TOPICAL APPLYING COSMETIC YU RUEY J (US) 2004-11-30 US disclosed
EP-1455734-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES Yu, Ruey J., Dr. (US) 2004-09-15 EP disclosed
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives YU RUEY J (US) 2003-06-12 US disclosed
WO-2003045338-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES YU RUEY J (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives GRHPR, ARL1, SUCLG1 ALDH1A1 1110/4885CYP3A4 4050/4885TSHR 3740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.